Signal transduction in endothelium-dependent vasodilatation.
Modulation of vascular tone is one important function of the endothelium. This can occur via two principal mechanisms: by modulating the local concentration of circulating vasoactive substances (e.g. adenine nucleotides, angiotensin II, biogenic amines, bradykinin), and by synthesizing and releasing vasoactive autacoids. The most important endothelium-derived vasodilator autacoids are nitric oxide (NO) and prostacyclin (PGI2). By counteracting neuro- and myogenic vasoconstriction, the continuous release of these autacoids from the vascular endothelium represents a sensitive and highly effective local system for maintaining an adequate blood flow to the organs. Impaired production of NO (and PGI2), either as a result of endothelial injury or dysfunction, has been implicated in the pathology of a variety of cardiovascular diseases, such as hypertension, hypercholesterolaemia, atherosclerosis and diabetes. Therefore, the prevention and/or reversal of the functional and morphological changes of the endothelium associated with these diseases is an important therapeutic goal. This brief overview covers current knowledge concerning the intracellular pathways that link endothelial activation by receptor-dependent and -independent stimuli to the formation of NO and PGI2.
Busse
R
R
Department of Applied Physiology, University of Freiburg, Germany.
Fleming
I
I
Hecker
M
M
D000818:Animals; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000502:physiology; D011464:Epoprostenol / Q000378:metabolism; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D012212:Rheology; D015398:Signal Transduction; D014664:Vasodilation / Q000502:physiology*
D009569:Nitric Oxide; D011464:Epoprostenol